Direkt zum Inhalt
Merck
  • Alpha-Tocopherol prevents esophageal squamous cell carcinoma by modulating PPARγ-Akt signaling pathway at the early stage of carcinogenesis.

Alpha-Tocopherol prevents esophageal squamous cell carcinoma by modulating PPARγ-Akt signaling pathway at the early stage of carcinogenesis.

Oncotarget (2017-12-10)
Miao Xu, Hui Yang, Qiannan Zhang, Ping Lu, Yongquan Feng, Xue Geng, Lishi Zhang, Xudong Jia
ZUSAMMENFASSUNG

The poor prognosis of esophageal squamous cell carcinoma (ESCC) emphasizes the urgent need to better understand the carcinogenesis and develop prevention strategies. Previous studies have highlighted the potential of using Vitamin E (tocopherols) for cancer chemoprevention, but the preventive activity of α-Tocopherol against ESCC remains to be elucidated. Our data showed that early-stage supplementation with α-Tocopherol significantly prevented esophageal carcinogenesis induced by

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Rosiglitazon, ≥98% (HPLC)
Sigma-Aldrich
(Tyr[SO3H]27)Cholecystokinin-Fragment 26-33 Amid, ≥97% (HPLC), powder
Sigma-Aldrich
MISSION® esiRNA, targeting human PPARG